DEXCOM INC. DL-,001/ US2521311074 /
20/05/2024 08:08:17 | Chg. -0.34 | Volume | Bid19:59:49 | Ask19:59:49 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
120.48EUR | -0.28% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 47.87 bill.EUR | - | - |
GlobeNewswire
08/04
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
31/01
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.